The Accelerated Phase of Chediak-Higashi Syndrome: The Importance of Hematological Evaluation

Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 1

Abstract

Chediak-Higashi syndrome is a rare autosomal recessive disease that was first described in 1943 by Bequez-Cesar in 3 siblings that bore the primary clinical features. In 1952 Chediak (a Cuban hematologist) and in 1954 Higashi (a Japanese pediatrician) described a series of cases characterized by misdistribution of myeloperoxidase in the patients’ neutrophilic granules [1,2].

Authors and Affiliations

Shreekant Bharti, Prateek Bhatia, Deepak Bansal, Neelam Varma

Keywords

Related Articles

Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient

To the Editor, Autoimmune hemolytic anemia (AIHA) is a rare, but clinically significant complication following hematopoietic stem cell transplantation (HSCT). It is characterized by hemolysis due to antibodies produced...

Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors

Over the last 50 years, the survival rates in children with acute lymphoblastic leukemia (ALL) have increased remarkably. The optimal use of antileukemic agents in cooperative group protocols, central nervous system-dire...

Download PDF file
  • EP ID EP163412
  • DOI 10.4274/tjh.2012.0027
  • Views 80
  • Downloads 0

How To Cite

Shreekant Bharti, Prateek Bhatia, Deepak Bansal, Neelam Varma (2013). The Accelerated Phase of Chediak-Higashi Syndrome: The Importance of Hematological Evaluation. Turkish Journal of Hematology, 30(1), 85-87. https://europub.co.uk/articles/-A-163412